Rapid Micro Biosystems (RPID) Price/OCF Ratio: History & Chart

Rapid Micro Biosystems, Inc.(RPID)

Medical - Devices · Lexington, MA

$0.96-0.02 (-1.81%)

Delayed quote: Oct 6, 2026, 3:59 PM EDT

About Rapid Micro Biosystems, Inc.

Rapid Micro Biosystems, Inc. operates as a life sciences technology firm, supplying advanced solutions for identifying microbial impurities in the production processes of pharmaceuticals, medical devices, and personal care goods across North America, Europe, and Asia. Central to their offerings is the Growth Direct platform, a comprehensive system comprising the Growth Direct instrument, specialized disposable components, software for seamless integration with laboratory information management systems (LIMS), and extensive customer validation and support services. This innovative platform is designed to automate and modernize traditional, labor-intensive microbial quality control (MQC) testing workflows, which are critical for diverse therapeutic modalities such as biologics, vaccines, cutting-edge cell and gene therapies, and sterile injectable medications. Beyond their core product, the company also delivers essential services, including system installation, verification, expert technical training, and continuous support. Their technologies are widely applied in vital areas like environmental monitoring, water quality testing, bioburden assessment, and final sterility release evaluations. Established in 2006, the company initially traded as Genomic Profiling Systems, Inc., before rebranding to Rapid Micro Biosystems, Inc. in January 2007, and maintains its headquarters in Lowell, Massachusetts.

Lexington, MA

171 employees

www.rapidmicrobio.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Robert G. Spignesi Jr.

View full financials

NAME	MARKET CAP	PRICE/OCF RATIO	TTM	3Y	5Y
Rapid Micro Biosystems, Inc. (RPID)	$43.45M	N/A	N/A	N/A	N/A
CVRx, Inc. (CVRX)vs ›	$42.99M	N/A	N/A	N/A	N/A
Nano-X Imaging Ltd. (NNOX)vs ›	$42.83M	N/A	N/A	N/A	N/A
BioStem Technologies, Inc. (BSEM)vs ›	$42.63M	N/A	9.67	15.53	36.04
DarioHealth Corp. (DRIO)vs ›	$44.49M	N/A	N/A	N/A	N/A
Filana Therapeutics, Inc. (FLNA)vs ›	$42.26M	N/A	N/A	N/A	N/A
SANUWAVE Health Inc. (SNWV)vs ›	$44.71M	8.56	102.83	129.05	129.05
Werewolf Therapeutics, Inc. (HOWL)vs ›	$44.72M	N/A	N/A	N/A	N/A
Precipio, Inc. (PRPO)vs ›	$41.83M	38.02	48.39	39.24	39.24
Celularity Inc. (CELU)vs ›	$45.73M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

PRICE/OCF RATIO

TTM

Rapid Micro Biosystems, Inc. (RPID)

$43.45M

N/A

CVRx, Inc. (CVRX)vs ›

$42.99M

N/A

Nano-X Imaging Ltd. (NNOX)vs ›

$42.83M

N/A

BioStem Technologies, Inc. (BSEM)vs ›

$42.63M

N/A

9.67

15.53

36.04

DarioHealth Corp. (DRIO)vs ›

$44.49M

N/A

Filana Therapeutics, Inc. (FLNA)vs ›

$42.26M

N/A

SANUWAVE Health Inc. (SNWV)vs ›

$44.71M

8.56

102.83

129.05

Werewolf Therapeutics, Inc. (HOWL)vs ›

$44.72M

N/A

Precipio, Inc. (PRPO)vs ›

$41.83M

38.02

48.39

39.24

Celularity Inc. (CELU)vs ›

$45.73M

N/A

Price/OCF Ratio Formula & Definition

P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.

Price/OCF Ratio: N/A

RPID Price/OCF Ratio Metrics

RPID Competitors' Price/OCF Ratio

Operating Cash Flow Valuation

Price/OCF Ratio Formula & Definition

Related Metrics